CTLA4 and heart failure: Recently, it has been demonstrated that blocking of T cell activation by abatacept, a cytotoxic T-lymphocyte-associated protein 4 (CTLA4)-Ig fusion protein, delays progression of TAC-induced heart failure (24, 25).